The visionary compliance company MyBlueLabel attracts experienced profiles to the board of directors, including former BioPorto CEO, Peter Mørch Eriksen, as chairman of the board

Monday 28-MAR-2022, Thomas Magnussen, Marie-Louise Little, and Peter Mørch Eriksen officially joined the board of the fast-growing compliance company, MyBlueLabel Compliance Services.

At an extraordinary general assembly on March 28th. 2022, MyBlueLabel Compliance Services established a board of directors and completed an investment round of DKK 5 million, and will change the company structure from ApS to A / S. This activity is carried out to accelerate the market introduction of their products and support MyBlueLabel’s growth plans to help 200 SMEs in Europe before the end of the year.

The MyBlueLabel software solution is built to help Life Science companies accelerate the process of developing a quality management system that enables them to easily navigate the regulatory rules to which the companies and their products are subject. This helps the companies understanding the minimum requirements for obtaining market access. We really want to support innovative companies that develop products that increase the quality of life for patients and users. To be able to attract strong and experienced profiles to our company and boards supports our mission to help as many startups, small and medium-sized businesses as possible … says Kenn Milton, CEO, MyBlueLabel, and continues: Regulatory compliance should be a central part of any business. We believe that only when you have control over compliance and the regulatory area can you truly innovate – and we want to make compliance a way of life (the easy way).

We know of the regulatory ‘headache’ most companies in this industry struggle with on daily basis.  MyBlueLabel presents an intuitive way of accelerating the regulatory framework while ensuring visual communication and transparency which is a business advantage for all companies … says Peter Mørch Eriksen.  The companies who understand this will win market shares – now and in the future.

From the left Thomas Magnussen, Kenn Milton, Marie-Louise Little and Peter Mørch Eriksen